Hunan Hansen Pharmaceutical Co., Ltd. (SHE:002412)

Market Cap	3.13B +8.2%
Revenue (ttm)	1.03B +1.3%
Net Income	225.27M +30.0%
EPS	0.45 +29.9%
Shares Out	503.20M
PE Ratio	13.90
Forward PE	n/a
Dividend	0.30 (4.73%)
Ex-Dividend Date	n/a

Volume	6,925,578
Open	6.33
Previous Close	6.22
Day's Range	6.00 - 6.33
52-Week Range	5.82 - 8.60
Beta	0.33
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 28, 2026

About SHE:002412

Hunan Hansen Pharmaceutical Co., Ltd. engages in the production and sale of traditional Chinese preparations in China and internationally. The company offers digestive system medicines; cardiovascular and cerebrovascular medicines; kidney-tonifying and urine-reducing medicines; trauma medicines; diagnostic medicines, etc. It provides medicines in injection, mixture, tablet, capsule, granule, syrup, decoction, tincture, and pill forms. Hunan Hansen Pharmaceutical Co., Ltd. is based in Yiyang, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1998
• Employees: 1,675
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002412

Financial Performance

In 2025, SHE:002412's revenue was 1.04 billion, an increase of 3.41% compared to the previous year's 1.00 billion. Earnings were 198.12 million, a decrease of -10.05%.